Clinical Trial

Provide Pre-approval Expanded Access of LY3437943

Available
View on ClinicalTrials.gov →
Summary
Provide pre-approval single patient expanded access of retatrutide for patients.
Trial Details
NCT Number NCT07629401
Lead Sponsor Eli Lilly and Company
Updated on ClinicalTrials.gov 2026-06-05